Oncology News

In this episode, host Shikha Jain, MD, speaks with Brian Fiske about bringing biotech business ideas to fruition, antibody drug conjugate developments and more.

In this edition, FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy, ivonescimab ‘may be a new standard’ and more.

Fewer cancer drugs were exempt from pediatric testing requirements after the Research to Accelerate Cures and Equity, or RACE, for Children Act went into effect in 2020, a study showed.

Mammography and digital breast tomosynthesis lead to very similar outcomes, so shared-decision making is important for breast cancer screening, according to an expert.

Ovarian cancer care costs are considerable, varying by care phase, age and geographic region, with the highest costs observed at initiation of and end-of-life care, researchers reported in the American Journal of Obstetrics and Gynecology.

False-positive mammography results discouraged women to return for further screenings, results from an observational cohort study published in the Annals of Internal Medicine showed.

The Inflation Reduction Act’s cap on out-of-pocket spending saved patients with cancer more than $7,000 a year on oral chemotherapy medications, a research letter analysis published in JAMA Network Open showed.

Less than three in 10 women are aware that a healthy diet can help reduce the risk for breast cancer, according to a recent survey.

Invasive aspergillosis occurs in around 3% to 5% of children with acute leukemia, according to findings published in Journal of the Pediatric Infectious Diseases Society.